Welcome to LookChem.com Sign In|Join Free
  • or
2-Hydrazinyl-3-iodopyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

54231-42-4

Post Buying Request

54231-42-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54231-42-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54231-42-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,2,3 and 1 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 54231-42:
(7*5)+(6*4)+(5*2)+(4*3)+(3*1)+(2*4)+(1*2)=94
94 % 10 = 4
So 54231-42-4 is a valid CAS Registry Number.

54231-42-4Downstream Products

54231-42-4Relevant academic research and scientific papers

Metal free [4+1] and [5+1] annulation reactions to prepare heterocycles using DMF and its derivatives as one-carbon source

Liu, Lingfeng,Qiao, Chunhua,Shen, Bei,Xu, Yiwen

supporting information, (2020/04/01)

1,2,4-Triazolo[3,4-a]pyridines and related heterocycles and substituted triazines were commonly discovered scaffolds in a variety of pharmaceutical and agrochemical agents. Herein, we report a highly efficient and practical method using DMF and its derivative for the [4+1] and [5+1] annulation reactions to prepare these heterocycles. This metal free reaction takes advantages of shelf stable DMF as solvent and carbon donor, imidazole chloride as a catalyst, the mild reaction condition tolerates a broad substrate range and substitutes. The prepared 3-unsubstituted 1,2,4-triazolo[3,4-a]pyridine and derivatives allow further introduction of a variety of functional group1 at 3-position.

New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors

-

Page/Page column 35, (2009/12/04)

This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 54231-42-4